Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Han

Showing results (831-840 of 858) with videos related to

Pageof 86
Sort By:
Frontiers in Microbiology|March 21, 2022
Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural InfectionLi-Na Yan, Pan-Pan Liu, Xu-Gui Li, et al.
Journal of Cell Science|March 25, 2010
ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cellsHsin-Yuan Fang, Chia-Ling Chang, Shu-Han Hsu, et al.
Clinical and Translational Medicine|December 23, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysisShang-Gin Wu, Chao-Chi Ho, James Chih-Hsin Yang, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
Medrxiv : the Preprint Server for Health Sciences|October 6, 2021
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant SurgeLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Journal of Medicinal Chemistry|July 18, 2023
Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary FibrosisWei-Chieh Yu, Tsung-Yu Yeh, Chih-Hung Ye, et al.
IEEE Journal of Translational Engineering in Health and Medicine|July 31, 2025
Evaluating Cardiac Impairment From Abnormal Respiratory Patterns: Insights From a Wireless Radar and Deep Learning StudyChun-Chih Chiu, Wen-Te Liu, Jiunn-Horng Kang, et al.
Bioactive Materials|April 13, 2022
Long-term safety and absorption assessment of a novel bioresorbable nitrided iron scaffold in porcine coronary arteryJian-Feng Zheng, Zi-Wei Xi, Yang Li, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 13, 2021
Using the Symptom Patient Similarity Network to Explore the Difference between the Chinese and Western Medicine Pathways of Ischemic Stroke and its ComorbiditiesLunzhong Zhang, Shu Han, Manli Zhao, et al.
Journal of Ethnopharmacology|March 8, 2024
Identification of anti-fibrotic and pro-apoptotic bioactive compounds from Ganoderma formosanum and their possible mechanisms in modulating TGF-β1-induced lung fibrosisKuan-Chen Cheng, Patrick Chun Theng Chong, Chen-Che Hsieh, et al.
Pageof 86

Showing results (831-840 of 858) with videos related to

Sort By:
Pageof 86
Frontiers in Microbiology|March 21, 2022
Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural InfectionLi-Na Yan, Pan-Pan Liu, Xu-Gui Li, et al.
Journal of Cell Science|March 25, 2010
ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cellsHsin-Yuan Fang, Chia-Ling Chang, Shu-Han Hsu, et al.
Clinical and Translational Medicine|December 23, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysisShang-Gin Wu, Chao-Chi Ho, James Chih-Hsin Yang, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
Medrxiv : the Preprint Server for Health Sciences|October 6, 2021
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant SurgeLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Journal of Medicinal Chemistry|July 18, 2023
Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary FibrosisWei-Chieh Yu, Tsung-Yu Yeh, Chih-Hung Ye, et al.
IEEE Journal of Translational Engineering in Health and Medicine|July 31, 2025
Evaluating Cardiac Impairment From Abnormal Respiratory Patterns: Insights From a Wireless Radar and Deep Learning StudyChun-Chih Chiu, Wen-Te Liu, Jiunn-Horng Kang, et al.
Bioactive Materials|April 13, 2022
Long-term safety and absorption assessment of a novel bioresorbable nitrided iron scaffold in porcine coronary arteryJian-Feng Zheng, Zi-Wei Xi, Yang Li, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 13, 2021
Using the Symptom Patient Similarity Network to Explore the Difference between the Chinese and Western Medicine Pathways of Ischemic Stroke and its ComorbiditiesLunzhong Zhang, Shu Han, Manli Zhao, et al.
Journal of Ethnopharmacology|March 8, 2024
Identification of anti-fibrotic and pro-apoptotic bioactive compounds from Ganoderma formosanum and their possible mechanisms in modulating TGF-β1-induced lung fibrosisKuan-Chen Cheng, Patrick Chun Theng Chong, Chen-Che Hsieh, et al.
Pageof 86